Overview
Description
60 Degrees Pharmaceuticals Inc. is a biotechnology company that specializes in the discovery, development, and commercialization of treatments for infectious diseases, particularly those impacting travelers and other affected populations. The company is renowned for its focused efforts on addressing tropical diseases, leveraging its expertise to offer solutions where medical needs are unmet, such as malaria prevention. With innovative approaches in pharmaceutical research and development, 60 Degrees Pharmaceuticals Inc. plays a vital role in the pharmaceutical sector, enhancing healthcare outcomes. Its contributions are significant, as it targets diseases prevalent in underserved regions, working towards creating sustainable health solutions globally. The company's focus on bringing advanced health innovations to the market positions it as a key player in addressing global health challenges, while its strategic research initiatives underline its importance in both the biotechnology landscape and global public health efforts.
About
CEO
Dr. Geoffrey Stuart Dow Ph.D.
Employees
3
Address
1025 Connecticut Avenue NW
Suite 1000
Washington, 20036, DC
United States
Suite 1000
Washington, 20036, DC
United States
Phone
202 327 5422
Website
Instrument type
Common stock
Sector
Healthcare
Industry
Biotechnology
Country
United States
MIC code
XNCM